| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 16.7× | 12.5× | |
| Price / Book | 2.7× | 2.9× | |
| Price / Sales | 0.9× | 1.3× | |
| Price / Free cash flow | −37.6× | 11.5× | |
| EV / EBITDA | — | 6.8× | — |
| Earnings yield | 6.0% | 8.0% | |
| Free cash flow yield | −2.7% | 3.7% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
GLKAR:GLAXOGlaxoSmithKline Pakistan Ltd · 🇵🇰 KAR | Rs 313.98 | +0.49% | $360.61M | 9.9× | 29.8% | −21.6% |
ABKAR:ABOTAbbott Laboratories (Pakistan) Ltd · 🇵🇰 KAR | Rs 947.72 | +0.35% | $331.56M | 11.5× | 25.2% | −21.3% |
HAKAR:HALEONHaleon Pakistan Ltd · 🇵🇰 KAR | Rs 677.36 | −1.02% | $284M | 12.5× | 43.1% | −24.0% |
HIKAR:HINOONHighnoon Laboratories Ltd · 🇵🇰 KAR | Rs 938.27 | +0.68% | $176.6M | 11.8× | 30.0% | −19.1% |
SEKAR:SEARLThe Searle Co Ltd · 🇵🇰 KAR | Rs 76.32 | −1.83% | $163.44M | 104.6× |
| 1.3% |
| −30.6% |
AGKAR:AGPAGP Ltd · 🇵🇰 KAR | Rs 165.06 | −1.97% | $160.41M | 12.1× | 24.2% | −16.3% |
HPKAR:HPLHoechst Pakistan Ltd · 🇵🇰 KAR | Rs 4,055.64 | +0.51% | $140.47M | 13.3× | 35.4% | −4.7% |
FEKAR:FEROZFerozsons Laboratories Ltd · 🇵🇰 KAR | Rs 334.35 | −0.26% | $52.17M | 18.6× | 6.3% | −17.3% |
CPKAR:CPHLCiti Pharma Ltd · 🇵🇰 KAR | Rs 62.35 | +1.12% | $51.79M | 15.9× | 8.2% | −30.6% |
BFKAR:BFBIOBF Biosciences Ltd · 🇵🇰 KAR | Rs 126.07 | −2.01% | $40.63M | 25.7× | 9.6% | −17.0% |
